Angiodynamics announces sale of dialysis product portfolio and biosentry product to merit medical systems for $100 million

Latham, n.y.--(business wire)--angiodynamics, inc. (nasdaq: ango), a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients, today announced that it has completed the sale of its dialysis product portfolio and biosentry tract sealant system biopsy product to merit medical systems, inc. for $100 million in cash. the transaction consists of angiodynam.
ANGO Ratings Summary
ANGO Quant Ranking